行业研究 2025.03.10 商 贸 零 售 行 业 周 报 天猫"3.8"首日可复美/毛戈平/绽家排名显著进阶，孩子王与头部算力算法企业合作布局 AI+ 方 正 证 券 研 究 所 证 券 研 究 报 告 分析师 | 刘章明 | 登记编号：S1220523050001 | | --- | --- | | 周昕 | 登记编号：S1220524100007 | | 陈佳妮 | 登记编号：S1220520080002 | | 谷寒婷 | 登记编号：S1220524030001 | | 廖捷 | | --- | | 联系人 | 行业评级 : 推 荐 | 行 | 业 | 信 | 息 | | | --- | --- | --- | --- | --- | | 上市公司总家数 | | | | 144 | | 总股本(亿股) | | | | 2,923.62 | | 销售收入(亿元) | | | | 21,639.47 | | 利润总额(亿元) | | | | 1,570.81 | | 行业平均 PE | | | | 24.83 | | 平均股价(元) | | | | 15.49 | 行 业 相 对 指 数 表 现 -2 ...

Investment Rating - The industry investment rating is "Outperform the Market," indicating that the industry index is expected to perform better than the market by more than 5% over the next six months [33]. Core Insights - The high-end beauty market in China has experienced rapid growth from 2017 to 2021 but is currently influenced by the overall macro environment and consumer sentiment. Domestic leading brands have strengthened their competitiveness in product formulation, design, marketing, and brand operation, leveraging e-commerce channels to quickly gather consumer demand and respond to market changes. Brands like Proya and Juzhibio are expected to capture market share as they cater to the demand for quality products at lower price points, pushing out Japanese and Korean cosmetics [2][9]. - The solid-state battery technology is emerging as a significant advancement in battery performance, with potential applications in various sectors, including low-altitude flying vehicles and humanoid robots. The technology is expected to overcome the limitations of traditional liquid lithium batteries, with domestic companies actively developing solid-state battery production capabilities [4][16]. Summary by Sections Beauty Industry - The domestic beauty market has shown a significant increase in sales during promotional events, with GMV exceeding 11.3 billion yuan during the 3.8 promotional period, marking a 71.86% increase year-on-year. Skincare and makeup categories also saw substantial growth [7][8]. - Leading domestic brands like Proya, Juzhibio, and others have maintained strong positions in the market, with Proya consistently ranking first in beauty sales on platforms like Tmall [8][9]. Solid-State Battery Industry - Solid-state batteries are positioned to break through existing performance bottlenecks, with advancements in materials and technology expected to enhance energy density and safety. The industry is seeing a shift towards solid-state technology, with significant investments and developments from leading companies like CATL and Penghui Energy [4][15][16]. - The demand for solid-state batteries is driven by their superior energy density and safety features, making them suitable for applications in electric vehicles and new technology sectors. The supply chain is evolving, with companies focusing on innovative materials and production processes to meet future demands [15][16].

Investment Rating - The report suggests a positive outlook for the beauty and medical aesthetics industry, highlighting strong performances from specific companies during the promotional period [4]. Core Insights - The report emphasizes the resilience of domestic brands in the beauty sector, with a stable market share of 25% for domestic brands on Tmall compared to the previous year [2]. - Notable performances include Proya, which maintained its top position, and Juzibio, which improved its ranking significantly on Tmall [2]. - On Douyin, the beauty category's GMV reached over 11.3 billion yuan, marking a 72% increase from the previous year, with skincare and makeup categories showing substantial growth [3]. Summary by Sections Tmall Platform - The top four brands maintained their positions, with domestic brands holding a 25% market share, consistent with the previous year [2]. - Proya ranked first, while Juzibio's Kefu Mei moved up five places to eighth, driven by strong sales of its collagen products [2]. - Maogeping entered the top 20 for the first time, with significant sales from its caviar mask and cushion foundation [2]. Douyin Platform - The beauty category's GMV exceeded 11.3 billion yuan, a 72% increase year-on-year [3]. - Skincare products generated over 8.4 billion yuan, with a 65% increase from the previous year, while the makeup category saw a 106% growth, reaching over 2.4 billion yuan [3]. - Maogeping's makeup sales reached between 50 million to 75 million yuan, significantly improving its market position [3]. Overall Market Performance - Companies such as Juzibio, Maogeping, and Proya showed exceptional performance during the promotional period, indicating strong market dynamics [4].

Investment Rating - The report recommends several companies in the retail sector, including leading brands in various categories such as children's retail, beauty, medical aesthetics, and jewelry [5][6]. Core Insights - The report highlights the ongoing transformation of the company, focusing on quality retail and optimizing store operations to better match consumer demand in Changsha, where the consumer base is young and economically active [4][5][30]. - The company has undergone significant restructuring, reducing the number of its supermarkets from 343 to 96 and its department stores from 43 to 37 between 2021 and 2023, aiming to streamline operations and focus on core areas [3][12][17]. - The introduction of a new management team from a successful competitor has led to impressive sales growth in restructured stores, with some locations reporting sales increases of over 300% during peak periods [5][51]. Summary by Sections 1. Background and Progress of Restructuring - The company has faced continuous operational pressure since 2021, leading to a strategic overhaul that includes closing underperforming stores and focusing on core business areas [3][11][17]. - The restructuring process has been supported by a new management team, which is implementing comprehensive changes across various operational aspects [18][19]. 2. Consumer Structure and Characteristics in Changsha - Changsha's GDP has shown steady growth, with a projected increase of over 5.5% in 2025, indicating a robust economic environment for retail [30][31]. - The demographic profile of Changsha is notably young, with nearly 50% of the population aged 18-24, which drives demand for differentiated products and services [4][39]. 3. Performance of Reformed Stores - The report details the successful transformation of several stores, with significant increases in sales and customer traffic post-restructuring [5][51][58]. - Specific stores have reported remarkable sales figures, with daily sales reaching as high as 240.22 million yuan during peak periods [51]. 4. Key Company Financial Forecasts and Valuations - The report provides earnings per share (EPS) forecasts and price-to-earnings (PE) ratios for various recommended companies, indicating strong growth potential in the retail sector [6].

Investment Rating - The industry investment rating is "Increase" (maintained) [9] Core Viewpoints - The report highlights the approval of China's first CaHA facial filler, Aphranel® by Moyang Bio, which is expected to perform well in the market due to its innovative micro-sphere structure and high biocompatibility [2] - Jinbo Bio reported a significant revenue increase of 85.40% year-on-year, reaching 1.447 billion yuan, with a net profit growth of 144.65% to 733 million yuan, driven by new product development and market expansion [3][4] - The report emphasizes the long-term potential for medical aesthetics penetration to continue increasing, suggesting a focus on companies like Giant Bio, Jinbo Bio, and others in the sector [9] Summary by Sections New Product Approvals - The report discusses the approval of Aphranel® as the first CaHA injection in China, noting its superior clinical performance and safety profile [2] - Jinbo Bio launched the world's first collagen net product, targeting eye area rejuvenation through advanced technology [4] Financial Performance - Jinbo Bio's financial results for 2024 show a revenue of 1.447 billion yuan, marking an 85.40% increase, and a net profit of 733 million yuan, reflecting a 144.65% growth [3] Market Trends - The report indicates a growing trend in the medical aesthetics market, with an expectation for increased penetration rates and competitive dynamics among brands [9] - It highlights the differentiation in cosmetic channels and the competitive landscape, suggesting that leading domestic brands are likely to continue outperforming [9]

以下文章来源于智谷趋势Trend ，作者知远 智谷趋势Trend . 新中产的首席财富顾问 时代车轮滚滚而来。 作者 | 知远 来源 | 智谷趋势Trend （ID：yuanfangguanchaju） 2025，开年即暴击。 大年初九，一份聊天记录在社交平台广为流传。"韩束"母公司上美股份创始人吕义雄在工作群部署 "用AI替代人工" ，各部门裁员的 比例赫然在目： 法务 部门50%的人要淘汰，只留20%能用AI的人； 客服 部门95%的人要淘汰，只留5%能用AI的人； 新品创新中心 70%的人要淘汰，只留30%能用AI的人以及工艺把控的人； 内容创新部门 80%的人要淘汰，只留20%能用AI的人，一个团队做出20个团队的活。 尽管其后来回应"不是裁员，只是有些地方加人，有些地方减人，让运营更科学化，更有效率"，但这无疑也变相承认了一些人终将被 替代的现实——赤裸裸的"适AI者生存"。 曾为DeepSeek逆袭ChatGPT而振臂欢呼的打工人，没有想到，AI会这么快就兵临城下，威胁饭碗。 变化之迅猛，可能比很多人想象的更剧烈。 活都让AI干了，普通人还能守住工作吗？ 01 电视台一定需要主持人吗？ 餐厅一定需 ...

Core Viewpoint - The article highlights a significant shift in fund managers' investment strategies towards the Hong Kong consumer sector, driven by extreme undervaluation and a strong demand for reallocation after a period of severe sell-off in consumer stocks [1][2][6]. Group 1: Market Dynamics - The recent IPO of major milk tea brands like Gu Ming and Mi Xue Bing Cheng has sparked renewed interest in the Hong Kong consumer market, with Mi Xue Bing Cheng achieving a record subscription amount of HKD 1.83 trillion, reflecting a 5266 times oversubscription [2][4]. - Fund managers are increasingly optimistic about consumer stocks, as evidenced by the dramatic price increases of stocks like Nai Xue's Tea, which surged over 80% in just two days following the IPO news [2][3]. Group 2: Fund Manager Behavior - Fund managers have been actively reallocating their portfolios, moving from technology stocks to consumer stocks, as they seek to balance their positions and capitalize on the emerging opportunities in the consumer sector [5][6]. - The article notes that many previously high-weighted consumer stocks have been sold off to the point of being excluded from major fund portfolios, indicating a significant shift in investment focus [4][5]. Group 3: Valuation and Future Expectations - The decline in consumer stock valuations at the end of last year, exacerbated by the tech sector's performance, has created a favorable environment for fund managers to invest in consumer stocks, anticipating a rebound in consumer demand by 2025 [6][7]. - Fund managers are focusing on companies with solid fundamentals and attractive valuations, particularly in traditional consumer sectors like liquor, home appliances, and brand-name Chinese medicine, as they expect improved performance in the consumer market [7][6].

Financial Performance - Chicmax reported a revenue increase of 15% year-over-year, reaching RMB 1.2 billion for the first half of 2024[10]. - The company achieved a net profit margin of 20%, translating to a net profit of RMB 240 million[10]. - Future guidance estimates a revenue growth of 20% for the full year 2024, driven by new product launches and market expansion[10]. - KANS generated revenue of RMB 2,926.5 million in 1H2024, an increase of 184.7% compared to 1H2023, accounting for 83.6% of total revenue for the period[19]. - One Leaf's revenue in 1H2024 was RMB 125.1 million, a decrease of 38.6% from 1H2023, representing 3.5% of total revenue[22]. - Revenue from Baby Elephant in 1H2024 was RMB 174.1 million, a decrease of 7.9% compared to 1H2023, accounting for 5.0% of total revenue[28]. - Total revenue for 1H2024 was RMB 3,225.7 million, with three main brands contributing 92.1%, representing an increase of 127.1% year-on-year[28]. - Revenue for the first half of 2024 reached RMB 3,502,399, an increase of 120.5% compared to RMB 1,586,826 in the same period in 2023[192]. - Profit for the period reached RMB 412,425, a significant increase from RMB 100,938 in the same period last year, representing a growth of 309%[194]. Market Expansion and Product Development - Chicmax plans to launch three new skincare products in Q3 2024, targeting a 30% increase in market share[10]. - The company is expanding its market presence in Southeast Asia, with a projected investment of RMB 100 million over the next two years[10]. - Chicmax is investing in new technology for product development, aiming to reduce production costs by 10%[10]. - KANS launched a new single product, "Reviving Skin Essence," containing a self-developed ingredient, "TIRACLE PRO," in 1H2024[14]. - KANS is focused on consolidating its market position as a leading scientific anti-aging brand in China, aiming to meet increasing consumer demands through advanced technology[19]. - Newpage launched "Baby Cooling Cream" and "Baby Sunscreen Lotion" in 1H2024, focusing on sensitive skin solutions for babies[28]. Sales and Distribution Channels - Chicmax's e-commerce sales have increased by 40%, now accounting for 60% of total sales[10]. - KANS achieved a gross merchandise volume (GMV) of RMB3,444 million on Douyin in 1H2024, surpassing the full year GMV of RMB3,340 million for 2023, ranking first among beauty brands on the platform[6]. - The GMV of KANS's flagship store on Tmall increased by approximately 200% year-on-year, while the growth rate of JD's self-operated flagship store exceeded 400% as of June 30, 2024[12]. - KANS's online channel GMV growth rate reached 222.8% in 1H2024, ranking second among domestic cosmetics brands and first among top cosmetics brands[12]. - Online direct sales revenue rose by 179.0% from RMB983.8 million in 1H2023 to RMB2,745.2 million in 1H2024, primarily from platforms like Douyin and Tmall[78]. Research and Development - R&D expenses in 1H2024 were RMB78.3 million, up 43.9% from RMB54.4 million in 1H2023, representing 2.2% of revenue[34]. - The company plans to increase investments in R&D focusing on trendy core ingredients in skincare, including anti-aging technology and skin barrier repair[51]. - In 1H2024, the company applied for 24 new patents, including 8 invention patents, and was granted 11 patents[34]. Corporate Governance and Compliance - The Company has adopted the Model Code for securities transactions, confirming compliance by all Directors and Supervisors during 1H2024[91]. - The audit committee confirmed that the interim results are in compliance with applicable accounting standards and regulations[179]. - The Company will continue to review its corporate governance practices to maintain high standards[90]. Employee and Shareholder Engagement - The Company aims to improve its recruitment and training system to attract talents from prestigious universities and establish joint training projects with universities[46]. - The Employee Share Ownership Plan (ESOP) was established in 2016 to attract and retain talent, aligning the interests of shareholders, the company, and employees[146]. - The RSU Scheme was approved on December 14, 2023, to attract and retain talents critical to the long-term growth of the Group[156]. Financial Position and Assets - Total assets as of the reporting period were RMB3,466.974 million, while total liabilities were RMB1,341.437 million, resulting in total equity of RMB2,125.537 million[58]. - Cash and cash equivalents decreased to RMB 569,386 from RMB 697,689, a decline of 18.4%[197]. - The Group's liquidity position remains strong, with sufficient cash and bank balances to meet working capital requirements[84].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 CHICMAX Shanghai Chicmax Cosmetic Co., Ltd. 上海上美化妝品股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2145） 截至2024年6月30日止六個月中期業績公告 上海上美化妝品股份有限公司（「本公司」）董事（「董事」）會（「董事會」）公佈本 公司及其附屬公司（統稱「本集團」）截至2024年6月30日止六個月（「2024年上半 年」）的未經審核綜合中期業績，連同截至2023年6月30日止六個月（「2023年上半 年」）的比較數字。 表現摘要 | --- | --- | --- | --- | |----------|------------------------|--------------|-------| | | | | | | | 截至 6 月 30 | 日止六個月 | 變動 | | | 2024 年 人民幣百萬元 | 2023 年 ...

Financial Performance - Shanghai Chicmax reported a significant increase in revenue, achieving a total of CNY 1.5 billion, representing a year-on-year growth of 25%[1]. - The company’s net profit for the year reached CNY 300 million, reflecting a 15% increase compared to the previous year[1]. - Revenue increased to RMB4,190.7 million in 2023, up from RMB2,675.3 million in 2022, representing a growth of approximately 56.4%[13]. - Gross profit rose to RMB3,019.5 million in 2023, compared to RMB1,699.6 million in 2022, marking an increase of about 77.6%[13]. - Profit for the full year of 2023 was RMB461.7 million, significantly higher than RMB137.1 million in 2022, reflecting a growth of approximately 236.5%[13]. - The company’s cash flow from operations increased to CNY 400 million, indicating strong financial health and liquidity[1]. - The Group's total revenue for 2023 was RMB 4,190.7 million, a significant increase from RMB 2,675.3 million in 2022, representing a growth of 56.4%[82]. - The Group's profit for the year was RMB 461.7 million in 2023, compared to RMB 137.1 million in 2022, indicating a substantial increase in profitability[86]. Customer Growth and Market Expansion - User data indicated a growth in active customers, with a total of 5 million users, up 20% from the previous year[1]. - Future outlook includes a projected revenue growth of 30% for the next fiscal year, driven by new product launches and market expansion strategies[1]. - Chicmax plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[1]. - KANS brand achieved a gross merchandise volume (GMV) of approximately RMB3,340 million through Douyin in 2023, representing a year-on-year growth of about 374.4%[14]. - KANS secured the top position in Douyin's annual cosmetics brands ranking in 2023, highlighting its strong market presence[20]. Product Development and Innovation - The company is investing CNY 200 million in R&D for new product development, focusing on innovative skincare solutions[1]. - KANS launched new product series including Neige Blanc Skin-Whitening and Soothing Firming, targeting improvements in skin brightness and sensitivity[20]. - The company aims to continue developing additive-free, safe, organic, and minimalist skincare products to meet the growing demand for high-quality maternal and infant care products[33]. - The company launched several new brands in 2023, including ARMIYO, asnami, KYOCA, and 2032, focusing on sensitive skincare and high-end maternity products[37]. - The company introduced a new cyclic peptide and upgraded ordinary linear peptides to three-dimensional cyclic peptides, enhancing absorption and physiological activity[41]. Marketing and Brand Strategy - A new marketing strategy has been implemented, aiming to increase brand awareness by 40% through digital channels[1]. - KANS collaborated with social media influencers to create content that garnered over one billion views, enhancing brand visibility and consumer engagement[17]. - The company has focused on a multi-brand strategy, successfully launching several cosmetic brands to cater to diverse consumer needs[13]. Awards and Recognition - KANS received multiple awards in 2023, including "Annual Super Brand in Beauty Industry" and "Outstanding Case of New Domestic Brand Innovation"[21]. - The company won multiple awards in 2023, including the InnoCosme Ingredient Awards for its core ingredient Tiracle Pro and the Ringier Technology Innovation Award for Artemisia Annua Oil AN+[42]. Financial Health and Liquidity - The Group's debt to asset ratio improved to 35.1% in 2023 from 45.7% in 2022[87]. - Current ratio increased to 2.0 times as of December 31, 2023, compared to 1.7 times in 2022[87]. - The Group's liquidity position remains strong, with no material contingent liabilities reported as of December 31, 2023[87]. Corporate Governance - The board is committed to maintaining high corporate governance standards to safeguard shareholder interests and enhance corporate value[133]. - The Company has adopted the principles and code provisions of the Corporate Governance Code as the basis for its governance practices[133]. - The Board consists of a balanced composition of executive and non-executive directors, ensuring strong independent judgment[139]. Human Resources and Employee Development - The total remuneration cost for 2023 was RMB494.6 million, an increase from RMB473.6 million in 2022, reflecting a reasonable growth in employee compensation[43]. - The Company emphasizes training and development opportunities for female staff to promote gender diversity[191]. - The Company has established fair hiring practices and competitive remuneration to maintain a strong competitive advantage in the human resources market[44]. Risk Management - The Group's risk management includes a structured organization with the Board, Audit Committee, and various departments acting as different lines of defense[200]. - Major risks identified during the Reporting Period include business risks, financial risks, compliance risks, inside information, and internal control risks[200]. - The effectiveness of the risk management and internal control systems is reviewed annually, focusing on financial, operational, and compliance monitoring[200].